Cargando…
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
BACKGROUND: Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profiles suitable for pl...
Autores principales: | Malhotra, Akash, Thompson, Ryan, De Vos, Margaretha, David, Anura, Schumacher, Samuel, Sohn, Hojoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449112/ https://www.ncbi.nlm.nih.gov/pubmed/37616318 http://dx.doi.org/10.1371/journal.pone.0290496 |
Ejemplares similares
-
Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization–Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid
por: David, Anura, et al.
Publicado: (2023) -
Na'at le ba'ala' paalen = Adivina iluminando
Publicado: (2008) -
Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia
por: Jo, Youngji, et al.
Publicado: (2021) -
Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China
por: Pang, Yu, et al.
Publicado: (2013) -
Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort
por: Davies, Bethan, et al.
Publicado: (2018)